Skip to main content
. 2005 Sep 28;11(36):5685–5687. doi: 10.3748/wjg.v11.i36.5685

Table 2.

Evaluation of IFNα /5-FU combination therapy

Evaluation after 1st cycle patient n (%) Final results patient n (%)
CR 1 (3.6)
PR 16 (57.1) 5 (17.9)
NR 12 (42.9) 22 (78.6)

IFN, interferon; FU, fluorouracil; CR, complete response; PR, partial response; NR, no response.